Primary Record
celastrol
- In stock
- 3,794 g
- Purity
- 98.5 %
- CAS
- 34157-83-0
Compound Identifiers & Properties
- CAS
- 34157-83-0
- PubChem CID
- 122724
- SMILES
- CC1=C(C(=O)C=C2C1=CC=C3[C@]2(CC[C@@]4([C@@]3(CC[C@@]5([C@H]4C[C@](CC5)(C)C(=O)O)C)C)C)C)O
- Canonical SMILES
- CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)O)CC[C@]3(C)CC[C@]12C
Names & Synonyms
- celastrol
- Tripterin
- Tripterine
- 34157-83-0
- Celasterol
- triterpene
- Celastrol?
- Celastrol,Tripterin
- Celastrol (Standard)
- Celastrol, Celastrus scandens
- Spectrum_000335
- Celastrol (>85%)
- Pristimerin (Celastrol)
- CELASTROL [MI]
- CELASTROL 25MG
- RefChem:124284
- Spectrum2_000150
- Spectrum3_000233
- Spectrum4_001966
- Spectrum5_000805
- MFCD03424073
- D0I9XH
- C29H38O4
- UNII-L8GG98663L
- AC1L3V4O
- C12H16NS.Br
- L8GG98663L
- SCHEMBL14954
- BSPBio_001905
- DTXSID2040993
- KBioGR_002436
- KBioSS_000815
- SPECTRUM201664
- CHEBI:63959
- MLS002701906
- MLS006011086
- NSC70931
- DivK1c_000718
- 34157-83-0 (castrol)
- SPBio_000260
- 2,5-Dibromo-4-methylpyridine
- KQJSQWZMSAGSHN-JJWQIEBTSA-N
- NSC 70931
- NSC-70931
- (2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid
- 11-alpha-hydroxyandrostenedione
- AC1Q6P61
- CHEMBL301982
- orb1304608
- C12-H16-N-S.Br
- DTXCID0020993
- ERK5-5H14
- GTPL10386
- KBio1_000718
- KBio2_000815
- KBio2_003383
- KBio2_005951
- KBio3_001405
- NINDS_000718
- BDBM205457
- Celastrol =98.0% (by HPLC)
- GLXC-02518
- HMS1923A13
- HMS3649E12
- HMS3884G09
- HMS6019F07
- KST-1A4115
- CELASTROL (REFERENCE GRADE)
- BCP07973
- EBD30960
- EX-A7823
- AR-1A3014
- BBF-05811
- CC0152
- CCG-39919
- CID122724
- EBC-11155
- HB4605
- HY-13067R
- MSK157285
- s1290
- ZINC19795938
- Celastrol, >=98% (HPLC), solid
- AKOS025311497
- AC-6031
- ACN-035486
- C29-H38-O4
- CID:122724
- compound 2 [PMID: 28621943]
- CS-0409
- FC19885
- GS-6082
- (2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid
- IDI1_000718
- NCGC00178913-01
- NCGC00178913-02
- NCGC00178913-04
- NCGC00178913-05
- NCGC00178913-14
- NCGC00178913-15
- HY-13067
- J18.706B
- NCI60_038570
- S492
- SC-19832
- SID:53788029
- SMR004702874
- SY028490
- LS-157465
- A2604
- C2737
- FT-0776752
- N1731
- ST24050307
- 3-Hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic Acid
- H10498
- W-5302
- 157C830
- A822102
- AK-693/21141017
- C050414
- SR-05000002679
- Celastrol, 98%, Protease inbibitor - 25MG 25mg
- Q5057534
- SR-05000002679-1
- SR-05000002679-3
- SR-05000002679-4
- D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-2-oxo-, (20alpha)-
- 3-hydroxy-9beta,13alpha-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid
- 35327-72-1
- 1H-Pyrido(2,1-b)benzothiazolium, 2,3,4,4a-tetrahydro-10-methyl-, bromide
- 2,3,4,4a-Tetrahydro-10-methyl-1H-pyrido(2,1-b)benzothiazolium bromide
- 2-Oxo-3-hydroxy-24-norfriedela-1(10),3,5,7-tetraene-29-oic acid
- 2-Oxo-3-hydroxy-24-norfriedelane-1(10),3,5,7-tetraene-29-oic acid
- 24,25,26-Trinoroleana-1(10),3,5,7-tetraen-29-oic acid,3-hydroxy-9,13-dimethyl-2-oxo-, (9b,13a,14b,20a)-
- 4a-Methyl-1,2,3,4,4a,10-hexahydropyrido(2,1-b)benzothiazolyl bromide
- (20alpha)-3-hydroxy-2-oxo-D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oate
- (20alpha)-3-hydroxy-2-oxo-D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid
- (20R)-3-Hydroxy-2-oxo-24-nor-D:A-friedoolean-1(10),3,5,7-tetren-29-oic acid
- 24-NOR-D:A-FRIEDOOLEANA-1(10),3,5,7-TETRAEN-29-OIC ACID, 3-HYDROXY-2-OXO-
- 3-Hydroxy-2-oxo-24-nor-D:A-friedooleana-1(10),3,5,7-tetraen-29-oic acid
- (2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylicacid
- (2R,4aS,6aS,12bR,14aS,14bR)-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-2-picenecarboxylic acid
- (9-beta,13-alpha,14-beta,20-alpha)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid
- (9?,13?,14?,20?)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid
- (9b,13a,14b,20a)-3-Hydroxy-9,13-dimethyl-2-oxo-24, 25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid
- 1,2,3,4,4a,5,6,6a, 11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b, 14a-hexamethyl-11-oxo-2-Picenecarboxylic acid
- 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-, (2R,4aS,6aS,12bR,14aS,14bR)-
- 2-Picenecarboxylic acid,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-
- 24,25,26-TRINOROLEANA-1(10),3,5,7-TETRAEN-29-OIC ACID, 3-HYDROXY-9,13-DIMETHYL-2-OXO-, (9.BETA.,13.ALPHA.,14.BETA.,20.ALPHA.)-
- 24,25,26-Trinoroleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-9,13-dimethyl-2-oxo-, (9ss,13a,14ss,20a)-; 24-Nor-D:A-friedooleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-2-oxo- (7CI,8CI); D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-2-oxo-, (20a)-; (9ss,13a,14ss,20a)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid; 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-, (2R,4aS,6aS,12bR,14aS,14bR)-; 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-, [2R-(2a,4ass,6ass,12bss,14aa,14bss)]-; Celastrol; NSC 70931; Tripterin
- 3-Hydroxy-9.beta.,13.alpha.-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid